67
Views
30
CrossRef citations to date
0
Altmetric
Original Research

P2Y12 receptor-mediated activation of spinal microglia and p38MAPK pathway contribute to cancer-induced bone pain

, , , , , , , , & show all
Pages 417-426 | Published online: 16 Feb 2017

References

  • DelaneyAFleetwood-WalkerSMColvinLAFallonMTranslational medicine: cancer pain mechanisms and managementBr J Anaesth20081011879418492671
  • ColemanREClinical features of metastatic bone disease and risk of skeletal morbidityClin Cancer Res20061220 pt 26243s6249s17062708
  • WangLNYaoMYangJPCancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cordMol Pain201174821722369
  • YaoMChangXYChuYXAntiallodynic effects of propentofylline elicited by interrupting spinal glial function in a rat model of bone cancer painJ Neurosci Res201189111877188621812015
  • GeisCGraulichMWissmannAEvoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer painNeuroscience2010169146347420417692
  • KurpiusDNolleyEPDaileyMEPurines induce directed migration and rapid homing of microglia to injured pyramidal neurons in developing hippocampusGlia200755887388417405148
  • KobayashiKYamanakaHFukuokaTDaiYObataKNoguchiKP2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic painJ Neurosci200828112892290218337420
  • Tozaki-SaitohHTsudaMMiyataHUedaKKohsakaSInoueKP2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injuryJ Neurosci200828194949495618463248
  • IyuDGlennJRWhiteAEMode of action of P2Y(12) antagonists as inhibitors of platelet functionThromb Haemost201110519610620941457
  • LiuSYangJWangLTibia tumor-induced cancer pain involves spinal p38 mitogen-activated protein kinase activation via TLR4-dependent mechanismsBrain Res2010134621322320478276
  • ZhangYQJiGCWuGCZhaoZQExcitatory amino acid receptor antagonists and electroacupuncture synergetically inhibit carrageenan-induced behavioral hyperalgesia and spinal fos expression in ratsPain200299352553512406529
  • DanielJLDangelmaierCJinJAshbyBSmithJBKunapuliSPMolecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human plateletsJ Biol Chem19982734202420299442039
  • HollopeterGJantzenHMVincentDIdentification of the platelet ADP receptor targeted by antithrombotic drugsNature2001409681720220711196645
  • SasakiYHoshiMAkazawaCSelective expression of Gi/o-coupled ATP receptor P2Y12 in microglia in rat brainGlia200344324225014603465
  • KobayashiKFukuokaTYamanakaHNeurons and glial cells differentially express P2Y receptor mRNAs in the rat dorsal root ganglion and spinal cordJ Comp Neurol2006498444345416874807
  • MedhurstSJWalkerKBowesMA rat model of bone cancer painPain2002961–212914011932069
  • YaoMYangJPWangLNFeasibility of establishment of rat model of bone cancer pain by using Walker 256 cells cultured in vitro or in vivoZhonghua Yi Xue Za Zhi2008881388088418756951
  • SchweiMJHonorePRogersSDNeurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer painJ Neurosci19991924108861089710594070
  • HonorePRogersSDSchweiMJMurine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neuronsNeuroscience200098358559810869852
  • HaldANedergaardSHansenRRDingMHeegaardAMDifferential activation of spinal cord glial cells in murine models of neuropathic and cancer painEur J Pain200913213814518499488
  • RaghavendraVTangaFYDeLeoJAComplete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNSEur J Neurosci200420246747315233755
  • LiangLWangZLuNYangJZhangYZhaoZInvolvement of nerve injury and activation of peripheral glial cells in tetanic sciatic stimulation-induced persistent pain in ratsJ Neurosci Res201088132899291020544834
  • ZwerinaJHayerSRedlichKActivation of p38MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destructionArthritis Rheum200654246347216447221
  • DongHTianYKXiangHBTianXBJinXGThe cellular location and significance of p38alpha/beta isoforms in the lumbar spinal cord of the bone cancer pain ratsZhonghua Yi Xue Za Zhi2007871535717403314
  • SvenssonCIMedicherlaSMalkmusSRole of p38 mitogen activated protein kinase in a model of osteosarcoma-induced painPharmacol Biochem Behav200890466467518584857
  • AlmelaPGarcia-NogalesPRomeroAMilanesMVLaordenMLPuigMMEffects of chronic inflammation and morphine tolerance on the expression of phospho-ERK 1/2 and phospho-P38 in the injured tissueNaunyn Schmiedebergs Arch Pharmacol2009379331532318839150
  • CrownEDGwakYSYeZJohnsonKMHulseboschCEActivation of p38 MAP kinase is involved in central neuropathic pain following spinal cord injuryExp Neurol2008213225726718590729
  • WenYRSuterMRJiRRActivation of p38 mitogen-activated protein kinase in spinal microglia contributes to incision-induced mechanical allodyniaAnesthesiology2009110115516519104183
  • SchultzRMPotential of p38 MAP kinase inhibitors in the treatment of cancerProg Drug Res200360599212790339
  • CottrellJAMeyenhoferMMedicherlaSHigginsLO’ConnorJPAnalgesic effects of p38 kinase inhibitor treatment on bone fracture healingPain20091421–211612619167815
  • HansenRRNielsenCKNasserAP2´7 receptor-deficient mice are susceptible to bone cancer painPain201115281766177621565445
  • WatkinsLRHutchinsonMRRiceKCMaierSFThe “toll” of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting gliaTrends Pharmacol Sci2009301158159119762094